Home > Balance Sheet > NGL FINECHEM

NGL FINECHEM
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NGL FINECHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹2.19 Cr₹1.37 Cr₹1.91 Cr₹2.38 Cr₹0.99 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM ?

The latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM is ₹2.19 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹2.19 Cr
Mar2023₹1.37 Cr
Mar2022₹1.91 Cr
Mar2021₹2.38 Cr
Mar2020₹0.99 Cr

How is Deferred Tax Assets / Liabilities of NGL FINECHEM Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹2.19 Cr
60.15
Mar2023 ₹1.37 Cr
-28.20
Mar2022 ₹1.91 Cr
-19.76
Mar2021 ₹2.38 Cr
140.69
Mar2020 ₹0.99 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹654.0 Cr -2.3% -8.9% -52.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,390.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-2.3%

-8.9%

-52.7%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses